Trials / Completed
CompletedNCT00134810
Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
A Phase II Multicentre Multinational Prospective Randomised Double-blind Placebo-controlled Study Assessing the Efficacy and Safety of a Single Application of Three Doses of Dysport® in Patients With Upper Back Myofascial Pain Syndrome
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 381 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to determine which is the best dose of a drug known as Dysport to give when treating one's type of upper back pain. The study will also examine the side effects of this treatment and its overall effect on one's disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum toxin type A |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2006-05-18
- Completion
- 2006-05-18
- First posted
- 2005-08-25
- Last updated
- 2019-11-22
Locations
22 sites across 6 countries: Czechia, Germany, Italy, Poland, Portugal, Spain
Source: ClinicalTrials.gov record NCT00134810. Inclusion in this directory is not an endorsement.